Navigation Links
Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
Date:6/17/2013

e Irish High Court commencing on 19 June 2013.  The date on which the Proceedings will be finally determined is not yet known.

Elan Stockholders can continue to execute and deliver Further Revised Acceptance Documents in accordance with the Further Revised Offer Document and those Further Revised Acceptance Documents will, subject to the outcome of the Proceedings and the ultimate decision of the Irish Takeover Panel, be received and dealt with by Royalty Pharma in the same manner as if the Offer had not lapsed. Elan Stockholders should however be aware that, in the absence of a decision of the Irish Takeover Panel such as is described above, such execution and delivery of Further Revised Acceptance Documents will not create a contract binding on the Elan Stockholders or Royalty Pharma.

Royalty Pharma will update Elan Stockholders in due course as to the outcome of the Proceedings and the status of the Further Revised Acceptance Documents.

J.P. Morgan, together with its affiliate J.P. Morgan Cazenove, BofA Merrill Lynch, together with its affiliate Merrill Lynch International, Groton Partners and Investec are acting as financial advisers to Royalty Pharma.

Further information relating to the Further Increased Offer, including all announcements issued by or on behalf of Royalty Pharma, is available at www.royaltypharma.com.

Capitalized terms used but not defined in this announcement have the meaning given to them in the Further Revised Offer Document.

ENQUIRIES
Royalty Pharma
Pablo Legorreta
George Lloyd
Tel: +1 212 883 2275

J.P. Morgan (financial adviser)
Henry Gosebruch (New York, Tel: +1 212 270 6000)
Dwayne Lysaght / James Mitford / Christopher Dickinson (L
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Pharma Chairman Writes Open Letter to Elan Board
2. Royalty Pharma Announces Offer May Lapse (Be Withdrawn)
3. PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
4. Royalty Pharma Files Judicial Review Proceedings
5. Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan
6. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
7. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
8. Royalty Pharma Acceptances Announcement
9. Royalty Pharma Responds To Elans Tysabri Valuation
10. Royalty Pharma Response To Elans "Categorical View On Value"
11. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Invivotek L.L.C., a member of the ... that its animal research facility was awarded full ... Accreditation of Laboratory Animal Care International (AAALAC). AAALAC ... worldwide through voluntary accreditation and assessment programs. AAALAC ... use in 38 countries. Invivotek was ...
(Date:7/14/2014)... 14, 2014 Valeant Pharmaceuticals International, Inc. ... today announced it has filed a premerger notification ... (HSR) with the U.S. Federal Trade Commission (FTC) ... (NYSE: AGN). About Valeant Pharmaceuticals ... Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical ...
(Date:7/14/2014)... , July 14, 2014  Mallinckrodt plc (NYSE: ... QCOR ) today announced that the registration statement on Form ... by Mallinckrodt plc on May 16, 2014 and amended on ... Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt, ... on Form S-4 is available on the SEC,s EDGAR system, ...
Breaking Medicine Technology:Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 3Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 4Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 6Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 7
... WASHINGTON, Sept. 19 The Richard B. and ... Birch McCormick,Genomics Center at The George Washington ... the issues and implications around the growing ... This symposium is,intended to provide a valuable ...
... Mich., Sept. 19 A new topical lotion ... eliminate serious skin,infections, but without being systemically absorbed, ... in patients with onychomycosis, or,toenail fungus, a new ... 1 clinical trial are important to the fields ...
Cached Medicine Technology:Personalized Medicine - The Genomic Revolution in Cardiac Care 2Personalized Medicine - The Genomic Revolution in Cardiac Care 3New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 2New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 3
(Date:7/14/2014)... Last month Bromell Agency officially launched the ... features more detailed information on how clients can protect ... and boats in the state of Louisiana. , The ... the website in order to better educate clients on ... of the website, which is to display comprehensive insurance ...
(Date:7/14/2014)... Academy, senescent is he who "begins to age". But ... is senescence not a synonym of ageing, it is ... is such a badly named physiological process that those ... another name. That is the case of Manuel Serrano, ... of the world,s leading experts on senescence, who has ...
(Date:7/14/2014)... 2014 Physical fitness may buffer some of the adverse ... new study by researchers from the American Cancer Society, ... study appears in the journal Mayo Clinic Proceeding ... and obesity and blood markers associated with cardiovascular disease ... , Sedentary behavior has been linked to an increase ...
(Date:7/14/2014)... Botanica Day Spa announced last month that their ... the day spa in down town Clearwater, FL on ... refreshments will be served as clients are invited to ... and great deals on spa services, including the ... (also known as “facial shaving”) is a simple and ...
(Date:7/14/2014)... -- Being physically active in middle age appears to ... types of dementia, suggest the findings from two new ... exercise at various levels, especially in midlife, is beneficial ... Clinic, said in an Alzheimer,s Association news release. ... conclusive. More research is needed to determine the extent ...
Breaking Medicine News(10 mins):Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3Health News:Physical fitness associated with less pronounced effect of sedentary behavior 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Staying Active May Help Prevent Dementia 2
... Food and Drug Administration,s (FDA) recent decision to approve ... treatment of non-Hodgkin,s lymphoma (NHL). "This is ... M. Graham, M.D., Ph.D., president of SNM and director ... College of Medicine. "We,ve known for some time that ...
... , ... superstore has beaten the thirty cents per card - three day production threshold on quantities ... Fort ... so few plastic cards so fast and at this price level. This is a special ...
... , , Members Take to ... with Constituent Health Care Stories to Congress , ... health care reform speech, and with Congress back to work in Washington, AARP ... what,s broken and preserve what,s right. , , ...
... , BELGRADE, Serbia, Sept. 10 /PRNewswire-FirstCall/ - HTDS ... its operating subsidiary Slavica Bio Chem www.slavicabiochem.com ... , , The equipment is ... http://www.expressionproteomics.com/LifeScience/pdf/Bulletin_3095.pdf , , , Dr.Ivana Gadjanski HTDS ...
... TEANECK, N.J., Sept. 10 After an 8 day trial, ... on September 4, 2009 by the Superior Court of New Jersey ... breaching her duty of loyalty. , , ... 2009, Ellen Koblitz, Presiding Judge of the Superior Court of New ...
... WALTHAM, Mass., Sept. 10 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the merger of ... several healthcare industry investor conferences during the month of September. , ... Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend ...
Cached Medicine News:Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:My1Stop.com Offers Plastic Card Printing Promotion Beats the Thirty Cents per Card Threshold - Offering 1000 Cards in Only Three Days for $299 2Health News:AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago 2Health News:Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects 2Health News:Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects 3Health News:Inverness Medical Innovations Announces September Investor Conference Schedule 2
... The VersaPulse® PowerSuite™ holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
... Cemex features a unique self-contained ... clinically proven in Europe for ... integrating bone cement powder and ... system, Cemex is designed to ...
Medicine Products: